- Home
- APGE vs CENT Comparison
APGE vs CENT Comparison
Compare APGE & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- CENT
- Stock Information
- Founded
- APGE 2022
- CENT 1955
- Country
- APGE United States
- CENT United States
- Employees
- APGE N/A
- CENT N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- CENT Consumer Specialties
- Sector
- APGE Health Care
- CENT Consumer Discretionary
- Exchange
- APGE Nasdaq
- CENT Nasdaq
- Market Cap
- APGE 2.0B
- CENT 2.2B
- IPO Year
- APGE 2023
- CENT N/A
- Fundamental
- Price
- APGE $37.63
- CENT $35.51
- Analyst Decision
- APGE Strong Buy
- CENT Strong Buy
- Analyst Count
- APGE 5
- CENT 2
- Target Price
- APGE $95.40
- CENT $42.50
- AVG Volume (30 Days)
- APGE 465.5K
- CENT 63.0K
- Earning Date
- APGE 11-11-2025
- CENT 08-06-2025
- Dividend Yield
- APGE N/A
- CENT N/A
- EPS Growth
- APGE N/A
- CENT N/A
- EPS
- APGE N/A
- CENT 2.14
- Revenue
- APGE N/A
- CENT $3,120,375,000.00
- Revenue This Year
- APGE N/A
- CENT N/A
- Revenue Next Year
- APGE N/A
- CENT $0.16
- P/E Ratio
- APGE N/A
- CENT $16.64
- Revenue Growth
- APGE N/A
- CENT N/A
- 52 Week Low
- APGE $26.20
- CENT $31.97
- 52 Week High
- APGE $63.50
- CENT $43.88
- Technical
- Relative Strength Index (RSI)
- APGE 50.77
- CENT 41.53
- Support Level
- APGE $36.01
- CENT $35.14
- Resistance Level
- APGE $37.97
- CENT $38.34
- Average True Range (ATR)
- APGE 1.66
- CENT 0.83
- MACD
- APGE 0.02
- CENT -0.10
- Stochastic Oscillator
- APGE 56.28
- CENT 11.56
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.